Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-tumor activity of CCI-779 in papillary renal cell cancer

Anti-tumor activity of CCI-779 in papillary renal cell cancer

US Patent 8791097 · Granted Jul 29, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dosage regimes for the administration of an anti-CD19 ADC2024
Combination therapy with an anti-CD25 antibody-drug conjugate2023
Dosage regimes for the administration of an anti-CD25 ADC2022
Dosage regimes for the administration of an anti-CD19 ADC2022
Treatment regimen utilizing neratinib for breast cancer2015
Cut-point in PTEN protein expression that accurately identifies tumors and is pr2012
Cut-point in PTEN protein expression that accurately identifies tumors and is pr2012
Use of CCI-779 as an antineoplastic agent2010
Use of CCI-779 as an antineoplastic agent2010
Combination therapy for the treatment of acute leukemia and myelodysplastic synd2010
Method of potentiating chemotherapy and treating solid tumors2008
Method of potentiating chemotherapy and treating solid tumors2008